Apellis Pharmaceuticals, Inc. (APLS)

21.75 -0.25 (-1.14%) USD  |  NASDAQ  |  Jan 23, 16:00
21.76 +0.01 (+0.05%) After-Hours: 20:00
More

Apellis Pharmaceuticals Return on Invested Capital (10y Median)

Return on Invested Capital (10y Median) Chart

View Return on Invested Capital (10y Median) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (10y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (10y Median) Range, Past 5 Years

View Return on Invested Capital (10y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (10y Median) Benchmarks

View Return on Invested Capital (10y Median) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade